Moreover, case–control studies also document lower levels of serum adiponectin in PC patients compared with healthy individuals. Human 22Rv1 and DU-145 PC cell lines were examined for the ...

In a Phase IIa study for MASH, subjects treated with the drug experienced a 2.3% weight loss over three months, accompanied by a significant increase in serum adiponectin levels. The drug's ...